OLBETAM Capsule Ref.[11088] Active ingredients: Acipimox

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2021  Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

Product name and form

Olbetam 250 mg Capsules.

Pharmaceutical Form

Red-brown/dark pink hard gelatin capsules, size no. 1, containing a white to cream powder.

Qualitative and quantitative composition

Acipimox 250.00 mg.

For the full list of excipients see section 6.1.

Active Ingredient Description
Acipimox

Acipimox inhibits the release of fatty acids from adipose tissue and reduces the blood concentrations of very low density lipoproteins (VLDL or Pre-beta) and low density lipoproteins (LDL or beta) with a subsequent overall reduction in triglyceride and cholesterol levels.

List of Excipients

Physically modified corn starch (STA-RX 1500)
Silica gel (Syloid 244)
Magnesium stearate
Sodium lauryl sulfate

Hard gelatin capsules shell:

Gelatin
Titanium dioxide (E171)
Iron oxide red (E172)
Iron oxide yellow (E172)

Pack sizes and marketing

Packed in blisters of 10 capsules per strip, inside cartons. Each carton contains 90 capsules.

Marketing authorization holder

Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

Marketing authorization dates and numbers

PL 00057/1022

2 May 2003

Drugs

Drug Countries
OLBETAM Netherlands, New Zealand, Singapore, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.